Pasar al contenido principal

HACIA LA APLICACION DE LAS PROTEINAS ANTIFUNGICAS DE HONGOS (AFPS): DESCIFRANDO SU ACCION ANTIFUNGICA Y PAPEL BIOLOGICO MEDIANTE EDICION GENETICA Y BIOLOGIA SINTETICA

PID2021-125858OB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2021
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 1
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Fighting pathogenic yeasts with plant defensins and anti-fungal proteins from fungi

  • Manzanares, Paloma
  • Giner-Llorca, Moisés
  • Marcos López, José Francisco
  • Garrigues, Sandra
Fungal infections represent a significant health risk worldwide. Opportunistic infections caused by yeasts, particularly by Candida spp. and their virulent emerging isolates, have become a major threat to humans, with an increase in fatal cases of infections attributed to the lack of effective anti-yeast therapies and the emergence of fungal resistance to the currently applied drugs. In this regard, the need for novel anti-fungal agents with modes of action different from those currently available is undeniable. Anti-microbial peptides (AMPs) are promising candidates for the development of novel anti-fungal biomolecules to be applied in clinic. A class of AMPs that is of particular interest is the small cysteine-rich proteins (CRPs). Among CRPs, plant defensins and anti-fungal proteins (AFPs) of fungal origin constitute two of the largest and most promising groups of CRPs showing anti-fungal properties, including activity against multi-resistant pathogenic yeasts. In this review, we update and compare the sequence, structure, and properties of plant defensins and AFPs with anti-yeast activity, along with their in vitro and in vivo potency. We focus on the current knowledge about their mechanism of action that may lead the way to new anti-fungals, as well as on the developments for their effective biotechnological production. KEY POINTS: • Plant defensins and fungal AFPs are alternative anti-yeast agents • Their multi-faceted mode of action makes occurrence of resistance rather improbable • Safe and cost-effective biofactories remain crucial for clinical application., Open Access funding provided thanks to the CRUE-CSIC agreement with Springer Nature. This work was supported by grant PID2021-125858OB-100 and the Severo Ochoa Excellence Program CEX2021-001189-S funded by MCIN/AEI/ https://doi.org/10.13039/501100011033 and by “ERDF: A way of making Europe.” This study forms part of the AGROALNEXT program and was supported by MCIN with funding from European Union NextGenerationEU (PRTR-C17.I1) and by Generalitat Valenciana. S. G. holds a Juan de la Cierva Incorporación grant (IJC2020-042749-I) funded by MCIN/AEI/ https://doi.org/10.13039/501100011033, “ERDF: A way of making Europe” and ‘NextGenerationEU/PRTR.’ M. G. L. was a recipient of a predoctoral grant FPU19/02066 funded by MCIN/AEI/ https://doi.org/10.13039/501100011033 and by “ESF: Investing in your future.”, With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX 2021-001189-S), Peer reviewed